Precision Medicine Market size to grow by USD 54.07 billion from 2022 to 2027|Growing prevalence of chronic diseases to boost market growth - Technavio

NEW YORK, July 4, 2023 /PRNewswire/ -- The precision medicine market size is estimated to grow by USD 54.07 billion from 2022 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 11.32% during the forecast period. Technavio estimates that the growth momentum will be progressing. For more insights on the historic (2017 to 2021) and forecast market size (2023 to 2027) - Request a sample report

What's New?

• Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession 
• Global competitiveness and key competitor positions 
• Market presence across multiple geographical footprints - Strong/Active/Niche/Trivial - buy the report!

Precision Medicine Market - Segmentation Assessment
Segment Overview
Technavio has segmented the market based on application (Oncology, CNS, Respiratory, Immunology, and Others), technology (Bioinformatics, Gene sequencing, Drug discovery, Precision molecular diagnostic, and Big data analytics), and geography (North America, Europe, Asia, and Rest of World (ROW)). 

• The market share growth by the oncology segment will be significant during the forecast period. Precision medicine permits doctors to develop personalized treatment plans tailored to specific genetic mutations. Doctors can identify specific molecular pathways involved in the development and progression of cancer. Precision medicine has different applications in oncology. When compared to traditional chemotherapy, these drugs have fewer side effects and more effectiveness. They hinder the growth and spread of cancer while minimizing harm to healthy tissues. Also, precision medicine is used in immunotherapy, which uses a patient's immune system to treat cancer. Additionally, precision medicine is used to identify patients at higher risk of developing certain types of cancer. Therefore, the rising use of precision medicine in oncology will fuel the growth of this segment during the forecast period.

Geography Overview
By geography, the global precision medicine market is segmented into North America, Europe, Asia, and the Rest of the World (ROW). The report provides actionable insights and estimates the contribution of all regions to the growth of the global precision medicine market.

• North America is estimated to account for 44% of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. In North America, the growth of the market is attributed to factors such as high healthcare spending, developed healthcare infrastructure, and a strong focus on R&D. During the forecast period, advances in technology, the increasing demand for personalized medicine, and the rising prevalence of chronic diseases will further drive market growth. The growth of the precision medicine market will be driven by increased R&D spending and better healthcare infrastructure in the US. In the US, breast cancer is the most common type of cancer among women and the second leading cause of death. The geriatric female population is more prone to develop breast cancer. Therefore, the increasing incidence of cancer is also driving the growth of the precision medicine market.

Insights on the market contribution of various segments, including country and region wise historic data (2017 to 2021), and forecast market size (2023 to 2027) - Download a Sample Report

Precision Medicine Market – Market Dynamics
Key factor driving market growth

The growing prevalence of chronic diseases is notably driving the precision medicine market growth. Some of the common chronic diseases include diabetes, cardiovascular disease, cancer, respiratory diseases, and neurological disorders. The majority of chronic diseases are increasing across the world, which is propelling the demand for precision medicine. Another factor is the aging population is also driving the prevalence of chronic diseases. For instance, according to the World Health Organization (WHO), the number of people aged 60 years and above will double to 2.1 billion by 2050 globally. Changes in lifestyle, such as lack of physical activity, poor diet, and tobacco use, also increase the prevalence of chronic diseases. It offers a personalized treatment approach that can be tailored to the genetic and biological characteristics of individual patients, and this helps healthcare providers identify genetic and protein-based biomarkers associated with specific diseases, which can lead to the development of targeted therapies.

Leading trends influencing the market 

The growing use of artificial intelligence (AI) and machine learning (ML) in precision medicine is an emerging trend shaping the market. With the use of these technologies, extensive amounts of patient data can be analyzed in a short time to develop targeted and personalized treatments. Based on individual genetic and molecular profiles, AI and ML are being used in several areas of precision medicine. Moreover, the proliferation of AI/ML algorithms with precision medicine helps clinicians, doctors, and researchers solve challenging issues in personalized healthcare. Also, AI and ML can help identify potential drug targets and predict the efficacy of new drugs, thereby speeding up the drug discovery process. These technologies can also help identify patients that are most likely to benefit from a particular treatment, thereby enhancing the efficiency and success of clinical trials. Therefore, the increasing use of AI and ML in precision medicine is expected to help the growth of the global precision medicine market during the forecast period.

Major challenges hindering the market growth

Data privacy and security issues associated with precision medicine may hinder the precision medicine market growth. Precision medicine relies on the collection and research of enormous amounts of patient data, such as genetic and molecular information, medical history, and lifestyle factors. Nevertheless, this data is vulnerable to threats such as cyberattacks and data breaches. Thus, researchers and healthcare providers should implement strong security measures to protect patient data. It is necessary to ensure that the use of patient data is in compliance with data protection regulations. Before collecting and using their data, researchers and healthcare providers should obtain informed consent from patients. This can be achieved by working to establish standards and guidelines for data collection, storage, and sharing. Therefore, data privacy and security issues associated with precision medicine are expected to hinder the growth of the global precision medicine market during the forecast period.

Insights on Market Drivers, trends, & Challenges, historic period(2017 to 2021), and forecast period(2023 to 2027)- Request a sample report!

What are the key data covered in this Precision Medicine Market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the precision medicine market between 2023 and 2027
• Precise estimation of the precision medicine market size and its contribution to the market in focus on the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the precision medicine market across North America, Europe, Asia, and the Rest of the World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of precision medicine market vendors

Gain instant access to 17,000+ market research reports. 

Technavio's SUBSCRIPTION platform

Related Reports:

The nuclear medicine market is estimated to grow at a CAGR of 16.48% between 2022 and 2027. The size of the market is forecast to increase by USD 8,057.89 million. The nuclear medicine market is estimated to grow at a CAGR of 16.48% between 2022 and 2027. The size of the market is forecast to increase by USD 8,057.89 million. The nuclear medicine market is estimated to grow at a CAGR of 16.48% between 2022 and 2027. The size of the market is forecast to increase by USD 8,057.89 million. 

The cancer diagnostics market size is estimated to grow at a CAGR of 11.3% between 2022 and 2027. The market size is forecast to increase by USD 12,626.21 million. report extensively covers market segmentation by end-user (hospitals and clinics, and diagnostic laboratories), type (IVD, imaging, and IDT), and geography (North America, Europe, APAC, and the Rest of the World (ROW)). One of the key factors driving the global cancer diagnostics market growth is the high prevalence of cancer. 

Table of contents

1 Executive Summary

• 1.1 Market Overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Technology
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022 

• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global precision medicine market 2017 - 2021
• Exhibit 18: Historic Market Size – Data Table on global precision medicine market 2017 - 2021 ($ billion)

• 4.2 Application Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size – Application Segment 2017 - 2021 ($ billion)

• 4.3 Technology Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size – Technology Segment 2017 - 2021 ($ billion)

• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ billion)

• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application

• 6.1 Market segments 
• Exhibit 30: Chart on Application - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Application - Market share 2022-2027 (%)

• 6.2 Comparison by Application 
• Exhibit 32: Chart on Comparison by Application
• Exhibit 33: Data Table on Comparison by Application

• 6.3 Oncology - Market size and forecast 2022-2027
• Exhibit 34: Chart on Oncology - Market size and forecast 2022-2027 ($ billion)
• Exhibit 35: Data Table on Oncology - Market size and forecast 2022-2027 ($ billion)
• Exhibit 36: Chart on Oncology - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Oncology - Year-over-year growth 2022-2027 (%)

• 6.4 CNS - Market size and forecast 2022-2027
• Exhibit 38: Chart on CNS - Market size and forecast 2022-2027 ($ billion)
• Exhibit 39: Data Table on CNS - Market size and forecast 2022-2027 ($ billion)
• Exhibit 40: Chart on CNS - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on CNS - Year-over-year growth 2022-2027 (%)

• 6.5 Respiratory - Market size and forecast 2022-2027
• Exhibit 42: Chart on Respiratory - Market size and forecast 2022-2027 ($ billion)
• Exhibit 43: Data Table on Respiratory - Market size and forecast 2022-2027 ($ billion)
• Exhibit 44: Chart on Respiratory - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Respiratory - Year-over-year growth 2022-2027 (%)

• 6.6 Immunology - Market size and forecast 2022-2027
• Exhibit 46: Chart on Immunology - Market size and forecast 2022-2027 ($ billion)
• Exhibit 47: Data Table on Immunology - Market size and forecast 2022-2027 ($ billion)
• Exhibit 48: Chart on Immunology - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on Immunology - Year-over-year growth 2022-2027 (%)

• 6.7 Others - Market size and forecast 2022-2027
• Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)

• 6.8 Market opportunity by Application 
• Exhibit 54: Market opportunity by Application ($ billion)
• Exhibit 55: Data Table on Market opportunity by Application ($ billion)

7 Market Segmentation by Technology

• 7.1 Market segments 
• Exhibit 56: Chart on Technology - Market share 2022-2027 (%)
• Exhibit 57: Data Table on Technology - Market share 2022-2027 (%)

• 7.2 Comparison by Technology 
• Exhibit 58: Chart on Comparison by Technology
• Exhibit 59: Data Table on Comparison by Technology

• 7.3 Bioinformatics - Market size and forecast 2022-2027
• Exhibit 60: Chart on Bioinformatics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 61: Data Table on Bioinformatics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 62: Chart on Bioinformatics - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Bioinformatics - Year-over-year growth 2022-2027 (%)

• 7.4 Gene sequencing - Market size and forecast 2022-2027
• Exhibit 64: Chart on Gene sequencing - Market size and forecast 2022-2027 ($ billion)
• Exhibit 65: Data Table on Gene sequencing - Market size and forecast 2022-2027 ($ billion)
• Exhibit 66: Chart on Gene sequencing - Year-over-year growth 2022-2027 (%)
• Exhibit 67: Data Table on Gene sequencing - Year-over-year growth 2022-2027 (%)

• 7.5 Drug discovery - Market size and forecast 2022-2027
• Exhibit 68: Chart on Drug discovery - Market size and forecast 2022-2027 ($ billion)
• Exhibit 69: Data Table on Drug discovery - Market size and forecast 2022-2027 ($ billion)
• Exhibit 70: Chart on Drug discovery - Year-over-year growth 2022-2027 (%)
• Exhibit 71: Data Table on Drug discovery - Year-over-year growth 2022-2027 (%)

• 7.6 Precision molecular diagnostic - Market size and forecast 2022-2027 
• Exhibit 72: Chart on Precision molecular diagnostic - Market size and forecast 2022-2027 ($ billion)
• Exhibit 73: Data Table on Precision molecular diagnostic - Market size and forecast 2022-2027 ($ billion)
• Exhibit 74: Chart on Precision molecular diagnostic - Year-over-year growth 2022-2027 (%)
• Exhibit 75: Data Table on Precision molecular diagnostic - Year-over-year growth 2022-2027 (%)

• 7.7 Big data analytics - Market size and forecast 2022-2027 
• Exhibit 76: Chart on Big data analytics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 77: Data Table on Big data analytics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 78: Chart on Big data analytics - Year-over-year growth 2022-2027 (%)
• Exhibit 79: Data Table on Big data analytics - Year-over-year growth 2022-2027 (%)

• 7.8 Market opportunity by Technology 
• Exhibit 80: Market opportunity by Technology ($ billion)
• Exhibit 81: Data Table on Market opportunity by Technology ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 83: Chart on Market share by geography 2022-2027 (%)
• Exhibit 84: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 85: Chart on Geographic comparison
• Exhibit 86: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 87: Chart on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 88: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 89: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 91: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 92: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 93: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 95: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 96: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 97: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 
• Exhibit 99: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 100: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 101: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027
• Exhibit 103: Chart on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 104: Data Table on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 105: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 Germany - Market size and forecast 2022-2027
• Exhibit 107: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 108: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 109: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 110: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.9 China - Market size and forecast 2022-2027
• Exhibit 111: Chart on China - Market size and forecast 2022-2027 ($ billion)
• Exhibit 112: Data Table on China - Market size and forecast 2022-2027 ($ billion)
• Exhibit 113: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 114: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.10 UK - Market size and forecast 2022-2027
• Exhibit 115: Chart on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 116: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 117: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 118: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.11 Japan - Market size and forecast 2022-2027
• Exhibit 119: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
• Exhibit 120: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
• Exhibit 121: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 122: Data Table on Japan - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 123: Market opportunity by geography ($ billion)
• Exhibit 124: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers 

• 10.2 Market challenges 

• 10.3 Impact of drivers and challenges 
• Exhibit 125: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends 

11 Vendor Landscape

• 11.1 Overview 

• 11.2 Vendor landscape 
• Exhibit 126: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption 
• Exhibit 127: Overview on factors of disruption

• 11.4 Industry risks 
• Exhibit 128: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered 
• Exhibit 129: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 130: Matrix on vendor position and classification

• 12.3 Amgen Inc. 
• Exhibit 131: Amgen Inc. - Overview
• Exhibit 132: Amgen Inc. - Product / Service
• Exhibit 133: Amgen Inc. - Key offerings

• 12.4 AstraZeneca Plc 
• Exhibit 134: AstraZeneca Plc - Overview
• Exhibit 135: AstraZeneca Plc - Product / Service
• Exhibit 136: AstraZeneca Plc - Key news
• Exhibit 137: AstraZeneca Plc - Key offerings

• 12.5 Bristol Myers Squibb Co. 
• Exhibit 138: Bristol Myers Squibb Co. - Overview
• Exhibit 139: Bristol Myers Squibb Co. - Product / Service
• Exhibit 140: Bristol Myers Squibb Co. - Key news
• Exhibit 141: Bristol Myers Squibb Co. - Key offerings

• 12.6 Catalent Inc. 
• Exhibit 142: Catalent Inc. - Overview
• Exhibit 143: Catalent Inc. - Business segments
• Exhibit 144: Catalent Inc. - Key news
• Exhibit 145: Catalent Inc. - Key offerings
• Exhibit 146: Catalent Inc. - Segment focus

• 12.7 Eli Lilly and Co. 
• Exhibit 147: Eli Lilly and Co. - Overview
• Exhibit 148: Eli Lilly and Co. - Product / Service
• Exhibit 149: Eli Lilly and Co. - Key offerings

• 12.8 F. Hoffmann La Roche Ltd. 
• Exhibit 150: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 151: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 152: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 153: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 154: F. Hoffmann La Roche Ltd. - Segment focus

• 12.9 Gilead Sciences Inc. 
• Exhibit 155: Gilead Sciences Inc. - Overview
• Exhibit 156: Gilead Sciences Inc. - Product / Service
• Exhibit 157: Gilead Sciences Inc. - Key news
• Exhibit 158: Gilead Sciences Inc. - Key offerings

• 12.10 Johnson and Johnson Services Inc.
• Exhibit 159: Johnson and Johnson Services Inc. - Overview
• Exhibit 160: Johnson and Johnson Services Inc. - Business segments
• Exhibit 161: Johnson and Johnson Services Inc. - Key news
• Exhibit 162: Johnson and Johnson Services Inc. - Key offerings
• Exhibit 163: Johnson and Johnson Services Inc. - Segment focus

• 12.11 Lonza Group Ltd. 
• Exhibit 164: Lonza Group Ltd. - Overview
• Exhibit 165: Lonza Group Ltd. - Business segments
• Exhibit 166: Lonza Group Ltd. - Key news
• Exhibit 167: Lonza Group Ltd. - Key offerings
• Exhibit 168: Lonza Group Ltd. - Segment focus

• 12.12 Merck and Co. Inc. 
• Exhibit 169: Merck and Co. Inc. - Overview
• Exhibit 170: Merck and Co. Inc. - Business segments
• Exhibit 171: Merck and Co. Inc. - Key news
• Exhibit 172: Merck and Co. Inc. - Key offerings
• Exhibit 173: Merck and Co. Inc. - Segment focus

• 12.13 Novartis AG 
• Exhibit 174: Novartis AG - Overview
• Exhibit 175: Novartis AG - Business segments
• Exhibit 176: Novartis AG - Key offerings
• Exhibit 177: Novartis AG - Segment focus

• 12.14 Pfizer Inc. 
• Exhibit 178: Pfizer Inc. - Overview
• Exhibit 179: Pfizer Inc. - Product / Service
• Exhibit 180: Pfizer Inc. - Key news
• Exhibit 181: Pfizer Inc. - Key offerings

• 12.15 Sanofi SA 
• Exhibit 182: Sanofi SA - Overview
• Exhibit 183: Sanofi SA - Business segments
• Exhibit 184: Sanofi SA - Key news
• Exhibit 185: Sanofi SA - Key offerings
• Exhibit 186: Sanofi SA - Segment focus

• 12.16 Takeda Pharmaceutical Co. Ltd. 
• Exhibit 187: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibit 188: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 189: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibit 190: Takeda Pharmaceutical Co. Ltd. - Key offerings

• 12.17 Thermo Fisher Scientific Inc. 
• Exhibit 191: Thermo Fisher Scientific Inc. - Overview
• Exhibit 192: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 193: Thermo Fisher Scientific Inc. - Key news
• Exhibit 194: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 195: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report 

• 13.2 Inclusions and exclusions checklist
• Exhibit 196: Inclusions checklist
• Exhibit 197: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 198: Currency conversion rates for US$

• 13.4 Research methodology 
• Exhibit 199: Research methodology
• Exhibit 200: Validation techniques employed for market sizing
• Exhibit 201: Information sources

• 13.5 List of abbreviations 
• Exhibit 202: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio